ASHLEY STIGER: Open Payments
NPI 1033710140 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 23 payments from 7 companies in 2025. Trend: 2023 $214 · 2024 $90 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $228 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| CVRx, Inc. | 1 | $27 |
| UCB, Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| HEARTFLOW, INC. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: CAMZYOS, VERQUVO, ELIQUIS, Barostim Neo System, Fintepla, NEXLETOL, FFRct, REPATHA.
Industry payments across LA — which companies pay providers there.
